New drug copy tested on healthy people
NCT ID NCT07479576
Summary
This study aims to see how a new drug called QL2106 compares to an existing drug, Tremfye, in healthy people. Researchers will give a single dose to 190 volunteers and measure how the body processes the drug, its safety, and how the immune system reacts. The goal is to gather initial data to see if QL2106 behaves similarly to the approved medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing GoBroad Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.